Home › Compare › RTSL vs JEPQ

RTSL vs JEPQ: Dividend Comparison 2026

RTSL yields 33333.33% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RTSL wins by $8.428195308647591e+21M in total portfolio value
10 years
RTSL
RTSL
● Live price
33333.33%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.428195308647591e+21M
Annual income
$8,378,748,509,141,157,000,000,000,000.00
Full RTSL calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — RTSL vs JEPQ

📍 RTSL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRTSLJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RTSL + JEPQ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RTSL pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RTSL
Annual income on $10K today (after 15% tax)
$2,833,333.33/yr
After 10yr DRIP, annual income (after tax)
$7,121,936,232,769,983,000,000,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, RTSL beats the other by $7,121,936,232,769,983,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RTSL + JEPQ for your $10,000?

RTSL: 50%JEPQ: 50%
100% JEPQ50/50100% RTSL
Portfolio after 10yr
$4.2140976543237957e+21M
Annual income
$4,189,374,254,570,578,700,000,000,000.00/yr
Blended yield
99.41%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RTSL buys
0
JEPQ buys
0
No recent congressional trades found for RTSL or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRTSLJEPQ
Forward yield33333.33% ✓11.10%
Annual dividend / share$2.00$6.16 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.428195308647591e+21M$44.8K ✓
Annual income after 10y$8,378,748,509,141,157,000,000,000,000.00 ✓$2,152.59
Total dividends collected$8.424943808765552e+21M$16.3K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RTSL vs JEPQ ($10,000, DRIP)

YearRTSL PortfolioRTSL Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$3,344,033$3,333,333.33$11,930$1,110.39+$3.33M → RTSL
2$1,045,333,048$1,041,754,932.50$14,133$1,224.34+$1045.32M → RTSL
3$305,463,295,767$304,344,789,404.97$16,632$1,340.46+$305463.28M → RTSL
4$83,443,192,327,233$83,116,346,600,762.75$19,454$1,457.97+$83443192.31M → RTSL
5$21,308,754,850,592,396$21,219,470,634,802,260.00$22,626$1,576.08+$21308754850.57M → RTSL
6$5,087,082,937,849,453,000$5,064,282,570,159,319,000.00$26,175$1,694.09+$5087082937849.43M → RTSL
7$1,135,355,897,925,379,400,000$1,129,912,719,181,880,500,000.00$30,133$1,811.32+$1135355897925379.50M → RTSL
8$236,895,694,937,506,160,000,000$235,680,864,126,726,020,000,000.00$34,531$1,927.17+$236895694937506176.00M → RTSL
9$46,211,962,155,546,610,000,000,000$45,958,483,761,963,480,000,000,000.00$39,403$2,041.08+$46211962155546607616.00M → RTSL
10$8,428,195,308,647,591,000,000,000,000$8,378,748,509,141,157,000,000,000,000.00$44,787$2,152.59+$8.428195308647591e+21M → RTSL

RTSL vs JEPQ: Complete Analysis 2026

RTSL — Stock

Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. The company engages in the aerosol delivery of non-psychoactive cannabinoids to the blood stream for treatment of chronic pain, post-traumatic stress disorder, insomnia, surgery recovery, and other ailments. It offers pressurized meter dose inhaler, a device that delivers a measured amount of aerosolized inhalant in a mist to the lungs; sublingual oral spray devices; and water-soluble cannabidiol and cannabigerol isolates under the nhaler brand. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc.

Full RTSL Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this RTSL vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RTSL vs SCHDRTSL vs JEPIRTSL vs ORTSL vs KORTSL vs MAINRTSL vs XYLDRTSL vs QYLDRTSL vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.